Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-7-28
|
pubmed:abstractText |
The purpose of this prospective study was to determine the incidence of any form of 21 alpha-hydroxylase deficiency among Greek women with hyperandrogenic symptoms, and to test the predictive value of basal serum 17-hydroxyprogesterone (17-OHP) in the early follicular phase as a screening index for patient preselection to adrenocorticotropic hormone (ACTH) testing. Eighty-eight unselected women with hyperandrogenic symptoms were examined in the Gynecological Endocrinology Unit of the Second Department of Obstetrics and Gynecology of Athens University. Using the ACTH-stimulated 17-OHP values at 60 minutes (17-OHP60) the study population was divided into four groups (A, B, C and D). Clinical and basal hormonal parameters as well as serum 17-OHP60 values and human leukocyte antigens were studied. Both clinical and basal hormonal parameters could be used to distinguish only patients with severe 21 alpha-hydroxylase deficiency (group A). In contrast, patients with moderate non-classical congenital adrenal hyperplasia (NC-CAH; group B), heterozygotes for NC-CAH (group C), and unaffected females (group D) can be diagnosed and classified only by serum 17-OHP60 values. In conclusion, the incidence of NC-CAH in Greek females with hyperandrogenic symptoms is 3.4%. The positive predictive value of basal 17-OHP is only 13% for this disease. Only 17-OHP60 helps to diagnose and classify moderate and mild forms of NC-CAH. Thus, it seems that ACTH testing is imperative in every subject suspected of this enzymatic disorder.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0951-3590
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-96
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9610421-17-alpha-Hydroxyprogesterone,
pubmed-meshheading:9610421-Adrenocorticotropic Hormone,
pubmed-meshheading:9610421-Adult,
pubmed-meshheading:9610421-Female,
pubmed-meshheading:9610421-Greece,
pubmed-meshheading:9610421-Humans,
pubmed-meshheading:9610421-Hyperandrogenism,
pubmed-meshheading:9610421-Mixed Function Oxygenases,
pubmed-meshheading:9610421-Predictive Value of Tests,
pubmed-meshheading:9610421-Prospective Studies
|
pubmed:year |
1998
|
pubmed:articleTitle |
The incidence of 21 alpha-hydroxylase deficiency in Greek hyperandrogenic women: screening and diagnosis.
|
pubmed:affiliation |
Second Department of Obstetrics and Gynecology, University of Athens, Greece.
|
pubmed:publicationType |
Journal Article
|